Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
9.74
+0.88 (9.93%)
At close: Jan 16, 2026, 4:00 PM EST
9.95
+0.21 (2.16%)
After-hours: Jan 16, 2026, 6:29 PM EST
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $182.16 million as of January 16, 2026.
Market Cap
182.16M
Enterprise Value
106.71M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.74
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $182.16M, a decrease of -15.08%. That is a compound annual growth rate of -17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 182.16M | 15.40% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |